middle.news
Optiscan Advances Head and Neck Imaging Study Ahead of Schedule
8:33am on Tuesday 21st of July, 2026 AEST
•
Healthcare
Read Story
Optiscan Advances Head and Neck Imaging Study Ahead of Schedule
8:33am on Tuesday 21st of July, 2026 AEST
Key Points
Stage 2 of head and neck cancer study begins early
In vivo imaging during surgery now underway
Study data to bolster US FDA submissions
Collaboration with St John of God and Australian Clinical Labs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Optiscan Imaging (ASX:OIL)
OPEN ARTICLE